Actavis Executive VP-U.S. Commercial And Administration Doug Boothe: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Boothe talks with “The Pink Sheet” DAILY about follow-on biologics and other issues facing the generics industry, as well as how the top-five generics company is positioning itself to thrive in an evolving global environment.